TrialBritish journal of cancer2013

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin.

M Tiseo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.